Tolerance to the protective effects of salmeterol on methacholine- induced bronchoconstriction: Influence of inhaled corticosteroids

European Respiratory Journal

Volumn 11, Issue 5, 1998, Pages 1091-1097

  Boulet, L P ^a,c   Cartier, A ^b   Milot, J ^a   Cote J ^a   Malo, J L ^b   Laviolette, M ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Asthma; Inhaled corticosteroids; Long acting 2 adrenoceptor agonists; Tolerance to bronchoprotective effects

Indexed keywords

SALBUTAMOL; SALMETEROL;

ADULT; ARTICLE; ASTHMA; BETA ADRENERGIC STIMULATION; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ASTHMA; BRONCHOCONSTRICTOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE;

EID: 0031866450     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11051091     Document Type: Article

References (27)

1. McFadden ER Jr, Gilbert IA. Asthma. N Engl J Med 1993; 327: 1928-1937.
2. Djukanovic R, Roche WR. Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-457.
3. Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987; 79: 734-740.
4. 2-agonists: implications for asthma management. Drugs 1994; 47 (2): 207-222.
5. Malo JL, Ghezzo H, Trudeau C, L'Archevêque J, Cartier A. Salmeterol, a new inhaled beta 2-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction. J Allergy Clin Immunol 1992; 89: 567-574.
6. Conolly ME, Hui Kit Ka, Borts SE, Jenne JW. Beta-adrenergic tachyphylaxis (desensitization) and functional antagonism. In; Jenne JW, Murphy S, eds. Drug Therapy for Asthma. New York. Marcel Dekker, 1987; pp. 259-296.
7. 2-adrenoceptor agonists: time for reappraisal. Br J Clin Pharm 1995; 39: 109-118.
8. 2-adrenoceptor agonists in asthma. N Engl Med 1992; 327: 1204-1208.
9. Ullman A, Hedner J, Svedmyr N. Inhaled salmeterol and salbutamol in asthmatic patients. Am Rev Kespir Dis 1990; 142: 571-575.
10. Bhagat R, Kalra S, Swystun VA, Cockcroft DW. Rapid onset of tolerance to bronchoprotective effect of salmeterol. Chest 1995; 108: 1235-1239.
11. Grove A, Lipworth BJ. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta-2 responses to fenoterol. Thorax 1996; 51: 585-589.
12. Verbene AAPH, Hop WCJ, Creyghton FBM, et al. Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma. J Allergy Clin Immunol 1996; 97: 938-946.
13. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992; 327: 1198-1203.
14. 2-adrenoceptor agonist salmeterol in mild to moderate asthmatic patients. Thorax 1993; 48: 1121-1124.
15. Tattersfield AK. Tolerance to beta-adrenoceptor agonists. Bull Eur Physiopathol Respir 1985; 21S: 1-5.
16. Sears MR. Long-acting beta-agonists, tachyphylaxis, and corticosteroids. Chest 1996; 109: 862-864.
17. Svedmyr N. Action of corticosteroids on adrenergic receptors. Clinical aspects. Am Rev Respir Dis 1990; 141: (Suppl.): S31-38.
18. Kalra S, Swystun VA, Bhagat R, Cockcroft DW. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest 1996; 109: 953-956.
19. American Thoracic Society Board of Directors. Standards for the diagnosis of patients with COPD and asthma. Am Rev Respir Dis 1987; 136: 225-244.
20. Juniper E, Cockcroft DW, Hargreave FE. Histamine and methacholine inhalation tests: tidal breathing method. Laboratory procedure and standardization. Canadian Thoracic Society, AB Draco, 1992.
21. Gibbons WJ, Sharma AJ, Lougheed D, Macklem PT. Detection of excessive bronchoconstriction in asthma. Am J Respir Crit Care Med 1996; 153: 582-589.
22. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Resp Med 1994; 88: 363-368.
23. International consensus report on diagnosis and treatment of asthma. Clin Exp Allergy 1992; Supp. 1: 1-72.
24. Ernst P, FitzGerald M, Spier S. Canadian Asthma Consensus Conference: summary of recommendations. Can Respir J 1996; 3: 89-100.
25. 2-receptor agonists and theophylline in the lung. Acta Pharmacol Toxicol 1979; 44: 216-220.
26. Booth H, Bish R, Walters J, Whitehead F, Walters EH. Salmeterol tachyphylaxis in steroid treated asthmatic subjects. Thorax 1996; 51: 1100-1104.
27. Yates DH, Kharitonov SA. Barnes PJ. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting beta-2-agonist. Am J Respir Crit Care Med 1996; 154: 1603-1607.